Whitney Williams is an associate in Goodwin Procter’s Antitrust and Competition practice. She helps obtain regulatory approval of mergers and acquisitions domestically and internationally, advises clients on antitrust risks assessments, and represents clients in complex antitrust litigation proceedings. Ms. Williams has experience representing clients across a broad range of industries, including private equity, emerging technologies, life sciences, financial industries, natural gas and electricity, pharmaceuticals, and healthcare.
Ms. Williams’ representative experience includes:
- G Squared Ascend I in its business combination of Transfix Inc. at an enterprise value of $1.1 billion
- TrueMotion in its acquisition by Cambridge Mobile Telematics
- Thoma Bravo LP in its sale of Pathwire to Sinch AB
- GeneWerk in its merger with PPS
- Celtra Technologies, Inc. in its investment by Symphony Technology Group
- JMI Equity in its investment in ServiceTrade
Ms. Williams is an active participant in Goodwin’s pro bono program advising and counseling clients alongside local and national non-profit organizations. She has handled matters related to immigration, housing rights, wrongful convictions, and international death penalty laws. While in law school, Ms. Williams participated in the Washington College of Law Civil Advocacy Clinic. She is also certified to represent individuals before the Department of Veterans Affairs.
American University Washington College of Law
BASociology, Minor Values, Law, and Policy2015
University of Houston
- Washington, D.C.
- New York
- Co-Author, “President Biden Announces a Three-Step Approach to Cannabis Reform: Federal Pardons, an Appeal to the States, and a Review of Cannabis Classification Under the Controlled Substances Act,” JDSupra, October 2022
- Contributing Author, “Private Antitrust Suits,” Antitrust Law Development Ninth Edition, 2022
- Co-Author, “UnitedHeathcare Subsidiary Indicted for No-Poach Agreements,” The National Law Review Volume XII, Number 285, January 13, 2021